Orchestra BioMed Holdings Inc (NASDAQ:OBIO) traded at $2.86 at close of the session on Tuesday, April 22 and made an upward move of 0.70% on its previous day’s price.
Looking at the stock we see that its previous close was $2.84 and the beta (5Y monthly) reads 0.618 with the day’s price range being $2.53 – $3.24. In terms of its 52-week price range, OBIO has a high of $8.87 and a low of $2.49. The company’s stock has lost about -36.59% over that past 30 days.
Orchestra BioMed Holdings Inc has a market cap of $109.58 million and is expected to release its quarterly earnings report on 2025-Mar-30.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 546.8k, with a low of 239k and a high of 880k. The median projection represents growth adding up to -11.81% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 2.58M, or -2.21% down from figures reported last year.
On the other hand, looking at the outlook for the OBIO stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Looking further, we note the current price level is -13.19% off its SMA20 and -30.34% from its 50-day simple moving average. The RSI (14) is pointing at 37.25 while the volatility over the past week is 13.44% and jumps to 14.63% over the past one month. The beta value is 0.82, while the average true range (ATR) is currently pointing at 0.44. The average price target for the stock over the next 12 months is $12, with the estimates having a low of $12 and a high of $12. These price ends are -319.58% and -319.58% off the current price level respectively, although investors could be excited at the prospect of a -319.58% if the OBIO share price touches on the median price of $12.
Coming back to Orchestra BioMed Holdings Inc (NASDAQ:OBIO), we note that the average 3-month trading volume was 57.78K, while that of the preceding 10-day period stands at 1.46 million. Current shares outstanding are 38.19 million.
The insiders hold 30.47% of the company’s shares while institutions hold 50.22%. The data shows that short shares as of 2025-03-31, stood at 0.57 million at a short ratio of 10.48. This represents a 264.00 short interest in shares outstanding on 2025-03-31. Shares short rose in March from the previous month at 0.52 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -28.50% down in year-to-date price movement.
